Zymeworks Inc. announced on February 18, 2025, the appointment of Oleg Nodelman to its board of directors, effective February 17, 2025. Mr. Nodelman is the Founder and Managing Director of EcoR1 Capital, LLC, a biotech-focused investment advisory firm and Zymeworks' largest current stockholder.
Mr. Nodelman brings over two decades of experience in investment management, business development, and capital deployment, along with deep roots in the biotech and scientific communities. His appointment is part of the company’s ongoing board renewal process, marking him as the seventh new director elected or appointed in the past two years.
Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks, stated that Mr. Nodelman's significant biotech sector experience will support the company's mission to develop transformative therapies and deliver lasting value to stockholders. This appointment is expected to enhance strategic oversight and align board interests with those of a major investor.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.